Navigation Links
NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database
Date:11/24/2009

The FBI recently approved the Promega PowerPlex 16 HS System for use by laboratories participating in or generating DNA records for the National DNA Index System.

Madison, WI USA (PRWEB) -- The FBI recently approved the Promega PowerPlex® 16 HS System for use by laboratories participating in, or generating DNA records for, the National DNA Index System (NDIS). NDIS currently contains more than seven million profiles and has assisted in over 94,000 investigations. It is populated with offender and forensic profiles from all 50 states, which makes it a powerful tool for identifying criminals nationwide.

The PowerPlex 16 HS System, released March 2009, has been optimized to increase success rates with challenging forensic samples and simplifies the workflow for offender databasing. The new system addresses these needs with a more robust reaction buffer and integrated hot start Taq DNA polymerase. Forensic samples often contain inhibitors that negatively impact DNA typing. The optimized reaction buffer increases tolerance for these common PCR inhibitors, resulting in strong results on even tough case samples. This increased capability also allows for direct analysis of database samples without DNA purification, which both simplifies the workflow for offender databasing and ultimately increases a laboratory’s productivity.

An inter-laboratory developmental validation study to support the NDIS approval is summarized in a report by Ensenberger, et al. and was published online this month in Forensic Science International Genetics. For more information on the PowerPlex 16 HS System, see www.promega.com/powerplex16hs

Promega Corporation has provided products for DNA-based human identification for over 20 years. Promega Corporation is a leader in providing innovative solutions and technical support to the life sciences industry. The company’s 2,000 products enable scientists worldwide to advance their knowledge in genomics, proteomics, cellular analysis, molecular diagnostics and human identification. Founded in 1978, the company is headquartered in Madison, WI, USA with branches in 14 countries and over 50 global distributors. For more information about Promega, visit www.promega.com.

# # #

Read the full story at http://www.prweb.com/releases/2009/11/prweb3249964.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Vasogen Inc. and IntelliPharmaCeutics Jointly Announce Shareholder Approval of Plan of Arrangement and Merger
2. China Medical Technologies Announces the SFDA Approval for its SPR System
3. Department of Energy Grants BlueFire Approval for Site Change
4. Sinovac Receives Certificate of Approval to Distribute Panflu (H5N1) Vaccine in Hong Kong
5. Varian, Inc. Announces Stockholder Approval of Merger Agreement With Agilent Technologies
6. Neuralstem Receives FDA Approval to Commence First ALS Stem Cell Trial
7. AMDL Inc. Announces Stockholder Approval of Name Change and Issuance of a New Trading Symbol on the NYSE Alternext US
8. Photo: Novartis Receives FDA Approval for Valturna(R), a Single-Pill Combination of valsartan and aliskiren, to Treat High Blood Pressure
9. EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean-in-Place Application
10. Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
11. SyntheMed Receives Brazilian Regulatory Approval for REPEL-CV(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 
(Date:2/21/2017)... /PRNewswire/ - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... three months ended December 31, 2016. SQI ... diagnostics company that develops and commercializes proprietary technologies and products ... ... commercial milestones achieved in fiscal 2016," said Andrew Morris ...
(Date:2/21/2017)... ... ... The medical potential of stem cells is both extensive and astounding, and ... their differentiating characteristics. Stem cells are unique as the have the potential to renew ... tissue or organic-specific cells with special functions. , Stem cell therapy in the ...
(Date:2/21/2017)... 21, 2017  Lexus, a returning partner of the Amgen ... and exclusive automobile partner of the men,s and women,s events for ... The 2017 Amgen Tour of California will ... of the best professional cycling teams in the world racing from ... four-day Amgen Breakaway from Heart Disease TM Women,s ...
(Date:2/20/2017)... (PRWEB) , ... February 20, 2017 , ... ... to announce that it has been approved for full, active membership in the ... Dallas, Texas, was founded by Chief Executive Officer Jeff Olson in ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017 Former 9/11 Commission ... Judiciary Committee, Janice Kephart of Identity Strategy ... Donald Trump,s "Executive Order: Protecting the Nation ... 27, 2017):  "As President Trump,s ,Travel Ban, ... has now essentially banned the travel ban, it is ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)... 7, 2017 Ipsidy Inc. ( ... [OTC: IDGS], ("Ipsidy" or the "Company") a provider of ... services, is pleased to announce the following changes as ... Effective January 31, 2017, Philip D. Beck ... and President.  An experienced payment industry professional and public ...
Breaking Biology News(10 mins):